147 related articles for article (PubMed ID: 20871272)
21. Complete response of multiple melanoma brain metastases after treatment with temozolomide.
Dvorak J; Melichar B; Zizka J; Hadzi-Nikolov D; Petera J
Onkologie; 2004 Apr; 27(2):171-4. PubMed ID: 15138351
[TBL] [Abstract][Full Text] [Related]
22. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases.
Addeo R; De Rosa C; Faiola V; Leo L; Cennamo G; Montella L; Guarrasi R; Vincenzi B; Caraglia M; Del Prete S
Cancer; 2008 Nov; 113(9):2524-31. PubMed ID: 18798231
[TBL] [Abstract][Full Text] [Related]
23. Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide.
Kuo LT; Tsai SY; Yang CY; Lin LW
Asian J Surg; 2017 Jan; 40(1):61-65. PubMed ID: 23978432
[TBL] [Abstract][Full Text] [Related]
24. Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
Benjelloun A; Delavelle J; Lazeyras F; Dietrich PY
Neurology; 2001 Nov; 57(10):1932-3. PubMed ID: 11723300
[No Abstract] [Full Text] [Related]
25. Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).
Dziadziuszko R; Ardizzoni A; Postmus PE; Smit EF; Price A; Debruyne C; Legrand C; Giaccone G;
Eur J Cancer; 2003 Jun; 39(9):1271-6. PubMed ID: 12763216
[TBL] [Abstract][Full Text] [Related]
26. Response of low-grade oligodendroglial tumors to temozolomide.
Byrne TN
J Neurooncol; 2004 Dec; 70(3):279-80. PubMed ID: 15662968
[No Abstract] [Full Text] [Related]
27. Successful treatment of a chemoresistant tumor with temozolomide in an adult patient: report of a recurrent intracranial mesenchymal chondrosarcoma.
Aksoy S; Abali H; Kiliçkap S; Güler N
J Neurooncol; 2005 Feb; 71(3):333-4. PubMed ID: 15735926
[No Abstract] [Full Text] [Related]
28. 10 questions about temozolomide and the treatment of brain tumors.
Pruitt AA; Rosenfeld MR
Neurologist; 2005 Nov; 11(6):362-5. PubMed ID: 16286879
[No Abstract] [Full Text] [Related]
29. Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.
Reni M; Ferreri AJ; Landoni C; Villa E
J Natl Cancer Inst; 2000 Apr; 92(7):575-6. PubMed ID: 10749917
[No Abstract] [Full Text] [Related]
30. Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation?
Boogerd W; de Gast GC; Dalesio O
Cancer; 2007 Jan; 109(2):306-12. PubMed ID: 17149755
[TBL] [Abstract][Full Text] [Related]
31. Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression.
Lolli I; Morra I; Cimmino A; Trevisan E; Rudà R; Piombino M; Campanella G; Gillio Tos A; De Marco L; Trevisan M; Fiano V; Soffietti R
J Clin Oncol; 2013 Aug; 31(23):e394-7. PubMed ID: 23796990
[No Abstract] [Full Text] [Related]
32. Temozolomide and unusual indications: review of literature.
Tatar Z; Thivat E; Planchat E; Gimbergues P; Gadea E; Abrial C; Durando X
Cancer Treat Rev; 2013 Apr; 39(2):125-35. PubMed ID: 22818211
[TBL] [Abstract][Full Text] [Related]
33. Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity.
Muldoon LL; Pagel MA; Netto JP; Neuwelt EA
J Neurooncol; 2016 Feb; 126(3):447-54. PubMed ID: 26694547
[TBL] [Abstract][Full Text] [Related]
34. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.
Agarwala SS; Kirkwood JM; Gore M; Dreno B; Thatcher N; Czarnetski B; Atkins M; Buzaid A; Skarlos D; Rankin EM
J Clin Oncol; 2004 Jun; 22(11):2101-7. PubMed ID: 15169796
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases.
Christodoulou C; Bafaloukos D; Kosmidis P; Samantas E; Bamias A; Papakostas P; Karabelis A; Bacoyiannis C; Skarlos DV;
Ann Oncol; 2001 Feb; 12(2):249-54. PubMed ID: 11300333
[TBL] [Abstract][Full Text] [Related]
36. Response to low dose temozolomide in radiation induced gliomatosis cerebri.
Hargrave D; Bouffet E; Gammon J; Becker L; Rutka J; Baruchel S
Med Pediatr Oncol; 2003 Dec; 41(6):562-4. PubMed ID: 14595716
[No Abstract] [Full Text] [Related]
37. [Complete response of cerebral metastasic melanoma after a combined treatment of radiotherapy and temozolomide].
Conill C; Puig S; Toscas I; Castel T
Med Clin (Barc); 2002 Nov; 119(19):758-9. PubMed ID: 12487980
[No Abstract] [Full Text] [Related]
38. Diagnosis and management of leptomeningeal disease.
Walker JG
Clin J Oncol Nurs; 2009 Aug; 13(4):384-7. PubMed ID: 19648093
[No Abstract] [Full Text] [Related]
39. Treatment of neoplastic meningitis with intrathecal temozolomide.
Sampson JH; Archer GE; Villavicencio AT; McLendon RE; Friedman AH; Bishop WR; Bigner DD; Friedman HS
Clin Cancer Res; 1999 May; 5(5):1183-8. PubMed ID: 10353755
[TBL] [Abstract][Full Text] [Related]
40. Going past the data for temozolomide.
Villano JL; Letarte N; Bressler LR
Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
